Ramin Mohammadzadeh

Ramin Mohammadzadeh

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Life Sciences
Verified
Journal Article
Closed access
MVMostafa Vaghari-Tabari
Mostafa Vaghari-Tabari
MMMaryam Majidinia
Maryam Majidinia
SMSoheila Moein
Soheila Moein
DQDurdi Qujeq
Durdi Qujeq
ZAZatollah Asemi
Zatollah Asemi
BYBahman Yousefi
Bahman Yousefi

4 July 2024 in Phytotherapy Research
Verified
Journal Article
Closed access
RMRamin Mohammadzadeh
Ramin Mohammadzadeh
MFM. Fathi
M. Fathi
MPM. M. Pourseif
M. M. Pourseif
YOY. Omidi
Y. Omidi
SFS. Farhang
S. Farhang
KAK. Adibkia
K. Adibkia

7 February 2014
Verified
Journal Article
Open access
RMRamin Mohammadzadeh
Ramin Mohammadzadeh
Behzad BaradaranBehzad Baradaran
Behzad Baradaran
HVHadi Valizadeh
Hadi Valizadeh
BYBahman Yousefi
Bahman Yousefi
PZParvin Zakeri-Milani
Parvin Zakeri-Milani
Purpose: P-glycoprotein (P-gp; ABCB1), an integral membrane protein in the apical surface of human intestinal epithelial cells, plays a crucial role in the intestinal transport and efflux leading to changes in the bioavailability of oral pharmaceutical compounds. This study was set to examine the potential effects of three Eudragits RL100, S100 and L100 on the intestinal epithelial membrane transport of rhodammine-123 (Rho-123), a substrate of P-gp using a monolayer of human colon cancer cell line (Caco-2).

27 July 2015 in Jundishapur Journal of Microbiology
Verified
Journal Article
Open access
PDF file
SHSeyyed Mortaza Haghgoo
Seyyed Mortaza Haghgoo
HJHadi Joula
Hadi Joula
RMRamin Mohammadzadeh
Ramin Mohammadzadeh
SSSiamak Sabour
Siamak Sabour
RYReza Yousefi
Reza Yousefi
ARAli A. R. Rahimi
Ali A. R. Rahimi
Background: This study was performed in response to the rapid propagation of HIV/AIDS across Iran and its status in this region. Accordingly, an evidence-based program is required to combat this disease. Objectives: The present study estimated the prevalence of HIV/AIDS in East Azerbaijan (population: 3,724,000). Materials and Methods: We created a database of all positive cases from 1987 to 2012. We also analyzed and described the epidemiological status of HIV/AIDS during a 25-year period by using SPSS. Results: In East Azerbaijan, 371 HIV/AIDS cases have been reported, i.e. 1 case per 10,000 population. The vast majority of reported cases (91%, n =338) were men, whereas only 9% (n = 33) were women. The mean age of patients was 30.8 ± 12.3 years. Unsafe drug injection (59%, n = 219) and sexual interaction (13%, n = 48) were the two major modes of HIV transmission. In addition, 7% (n = 25) of patients have been diagnosed with HIV, hepatitis B Virus, and hepatitis C virus simultaneously. Moreover, 60% (n = 205) of men were infected via drug injection, while 82% (n = 27) of women were infected via unprotected sexual interaction (P < 0.001). Conclusions: The results indicate a rapid increase in the number of HIV/AIDS cases in East Azerbaijan, necessitating immediate attention and strategies to combat the rapid spread of the disease. Development of provincial and national HIV/AIDS strategies demands more accurate and comprehensive HIV/AIDS surveillance. Keywords: HIV; Acquired Immunodeficiency Syndrome; Epidemiology


13 November 2018 in Pharmaceutical and Biomedical Research
Verified
Journal Article
Open access
RMRamin Mohammadzadeh
Ramin Mohammadzadeh
YJYousef Javadzadeh
Yousef Javadzadeh
Oral drug administration is used for a large number of medications, intended to create a systemic effect in the body. Over the recent years, an increasing attention has been directed by pharmacists toward the development of successful formulations for oral drug delivery. However, this issue is still controversial in pharmaceutical technology with many limitations due to the numerous barriers against the absorption and permeability in the gastrointestinal tract. On the other hand, drug carriers play an important role in providing prolonged release and delivery and overcome the multiple barriers of maintaining appropriate bioavailability. Nano scaling of the particles, carriers, and polymers has also provided the capability to characterize and control materials in order to produce unique pharmaceutical components and structures. Furthermore, personalized healthcare, rational drug design, and site-specific targeted drug delivery are some of the profits gained from a nano-based formulation approach. This review aimed to evaluate the evidence on some different types of nanoscaled drug delivery systems, which allow for the delivery of smallmolecule drugs and facilitate the merging of larger particles, such as nucleic acids, peptides, and proteins. The delivery of these molecules to the exact target areas inside the body can be accomplished, which would decrease systemic adverse effects and allow for more effective application of the pharmaceutical preparations.